Applied Research In Acoustics LLC — Department of Defense STTR Phase I: DTRA22D-001

Applied Research In Acoustics LLC — STTR Phase I award from Department of Defense.

Phase I STTR feasibility signal

  • Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
  • Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
  • Obligated amount $167,462. Cross-check similar awards in the same agency and technology tags for going-rate context.
  • Topic code DTRA22D-001 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$167,462
Agency
Department of Defense · Defense Threat Reduction Agency
Program / Phase
STTR · Phase I
Topic
DTRA22D-001
Solicitation
22.D
NAICS
Place of performance
VA
Period
2023-04-11 → 2023-11-11

Description

To address the challenge DTRA faces in identifying rare objects of interest to defeat improvised threat networks using multispectral imagery, small business ARiA and research institution Michigan Technological University (MTU) will develop and demonstrate the feasibility of the Generative Augmentation Process (GAP). The Phase I effort will (1) conduct a proof-of-concept study for GAP by developing and characterizing with quantitative metrics the performance of processes and algorithms to perform generative modeling of multispectral imagery across IR bands; (2) demonstrate that GAP can feasibly meet DTRA needs for the mission of defeating improvised threat networks and; (3) establish through Phase II planning that GAP can be developed into a useful product for DTRA and DoD. The Phase II development plan will address the reduction of technical risk based on assessment of the maturity of metrics and measures developed in Phase I and will provide guidance for risk-reducing activities conducted during Phase II.